UK Defense Ministry Awards Contract to Owlstone

MONTEBELLO, NY /Marketwire/ -- Advance Nanotech Inc. is pleased to announce that its subsidiary Owlstone Nanotech Inc. has been awarded an $80k contract from an agency of the UK Ministry of Defence for a 3-month investigation into the application of its core miniaturized Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) technology in ultra-trace vapor detection. Pending success of this three-month proof-of-principle stage, there is an opportunity for contract extension to a longer second phase in which field deployment trials would be undertaken.

Bret Bader, Owlstone's CEO, commented, "We are pleased to have received this contract which is set for delivery and completion during this first quarter of 2010. We are looking forward to working more closely with the MOD on a program that has the potential to demonstrate a novel application for our core technology."

About Advance Nanotech and Owlstone Nanotech
Advance Nanotech Inc. owns a minority position in Owlstone Nanotech Inc. Owlstone is a pioneer in the commercialization of chemical detection products. The Owlstone detector is a revolutionary dime-sized sensor that can be programmed to detect a wide range of chemical agents that may be present in extremely small quantities. Using leading-edge micro- and nano-fabrication techniques, Owlstone has created a complete chemical detection sensor that is significantly smaller and can be produced more cost effectively than products using existing technology. There are numerous applications—across industries, from security and defense to industrial process, air quality control, and healthcare—that depend on the rapid, accurate detection and measurement of chemical compounds. Owlstone works with market leaders within these industries to integrate the detector into next-generation chemical sensing products and solutions. Owlstone's technology offers a unique combination of benefits, including small size, low manufacturing costs, minimal power consumption, reduced false-positives, and a customizable platform.